Gainers
- Renovaro Biosciences RENB shares increased by 292.9% to $3.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $212.7 million.
- Decibel Therapeutics DBTX shares moved upwards by 75.26% to $4.89. The company's market cap stands at $122.3 million.
- Tango Therapeutics TNGX shares rose 33.68% to $5.12. The market value of their outstanding shares is at $452.9 million. As per the news, the Q2 earnings report came out 2 days ago.
- 180 Life Sciences ATNF shares increased by 32.24% to $1.02. The market value of their outstanding shares is at $5.4 million.
- Mirati Therapeutics MRTX stock increased by 21.11% to $33.67. The company's market cap stands at $1.9 billion. The company's, Q2 earnings came out yesterday.
- Akanda AKAN stock rose 19.35% to $0.72. The company's market cap stands at $2.8 million.
Losers
- Palisade Bio PALI shares fell 66.1% to $0.66 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.4 million.
- Doximity DOCS shares fell 23.0% to $25.25. The market value of their outstanding shares is at $4.9 billion. The company's, Q1 earnings came out yesterday.
- Vivos Therapeutics VVOS stock declined by 18.11% to $0.33. The market value of their outstanding shares is at $9.8 million.
- Monopar Therapeutics MNPR shares declined by 14.83% to $0.74. The company's market cap stands at $9.7 million.
- BioLife Solns BLFS shares fell 13.0% to $16.0. The market value of their outstanding shares is at $695.7 million. As per the press release, Q2 earnings came out yesterday.
- Comera Life Sciences CMRA stock fell 11.36% to $0.58. The market value of their outstanding shares is at $12.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in